Status:
COMPLETED
Androcur Effects on Quality of Life
Lead Sponsor:
Bayer
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Androcur is an antiandrogenic drug, which blocks the action of male sex hormones. Androcur is used for treatment of advanced prostate cancer. This study investigates the effect of Androcur on quality ...
Eligibility Criteria
Inclusion
- Histologically confirmed adenocarcinoma of the prostate
- Inoperable prostate tumor or progradiated after surgery/ irradiation therapy
- Locally advanced tumor or distant metastases is present
Exclusion
- Patient not fulfil the recruitment criteria
- Liver disease; Dubin-Johnson syndrome; Rotor syndrome; previous or existing liver tumours (in carcinoma of the prostate only if these are not due to metastases); wasting diseases (with the exception of carcinoma of the prostate); depression; previous or existing thromboembolic processes; diabetes with vascular changes; sickle-cell anaemia.
- As regards patients with prostatic carcinoma who have a history of thromboembolic processes and/or an existing sickle-cell anaemia, or diabetes with vascular changes, the risk:benefit ratio must be considered carefully in each individual case before the use of Androcur
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT00908674
Start Date
June 1 2008
End Date
January 1 2010
Last Update
April 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Hungary